Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Cardiome Pharma Corp T.COM

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  CRME

Cardiome Pharma Corp is a specialty pharmaceutical company engaged in the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.
Price: $9.07 | Change: $-0.10 | %Change: -1.09%
Volume: 3,500 | Day High/Low: 9.07/8.95 | 52 Week High/Low: 12.02/4.96
View modes: 
0 stars

Positive Data From Phase 3 Trial, Cardiome

Cardiome Pharma Corp. (COM.TO) Touts Positive Data From Phase 3 BRINAVESS® Trial Cardiome Announces Positive Results from the BRINAVESS® Asia-Pacific Phase 3 Clinical Trial  NASDAQ: CRME TSX...read more
0 stars

News to come on the 18th?

  rate and reply
0 stars

RE:Just Got Lucky This Time..

Noone is listening to you..or havent you noticed?This isnt one of your penny stocks.BTW do you ever read your own posts?  rate and reply
1 star

Just Got Lucky This Time..

sold all COM by luck to cover shortfall in trades elsewhere. Many pharmas. are dropping like a stone, not exactly pipeline and bank stocks here. So, put in your "sell on stops" frequently on this wild...read more
1 star

The Kind of '^Targets" We Like...

not the usual $1 or $1.30 left to the "upside" from current price. Canaccord Genuity has upgraded its then-target of $9.50 to a juicy $14.00 target. That's a neat 'n tidy 40% upside from current price...read more
1 star

Uchuck's ETF for Cndn. Pharma?

see my note under T.CXR, Concordia Health Care.  rate and reply
0 stars

RE:Medicure and Cardiome

Good News   Cardiome $ 30 million cash so that is an assumption of Medicure increasingly likely. Medicure very good chance.  In 6 months the Medicure is share either $ 5 or there was a...read more
0 stars

Medicure and Cardiome

Medicure's shares are significantly undervalued. Price target Medicure $ 2.80!  The chart speaks for a very bullish trend of the outbreak of the shares is imminent.  Medicure shares face a strong...read more
0 stars

just never can tell

When it was announced they were going it on their own in march it dipped to 40 cents.I panicked and sold 15000 shares between 39 and 45 cents . Just want to cry now . Wish the best to everyone on this...read more
0 stars

RE:Medicure and Cardiome .....

Very good News. Medicure BioTec TenBagger http://www.pmlive.com/pharma_appointments/cipher_names_gerald_mcdole_as_chair_541474?SQ_DESIGN_NAME=2  rate and reply
0 stars

RE:Medicure and Cardiome .....

http://www.stockhouse.com/companies/bullboard/v.mph/medicure-inc?postid=21948270  rate and reply
0 stars

Medicure and Cardiome .....

Medicure Market value very low 4.2 million CAD dollars.(Shares outstanding 12,100,000) Cardiome Market value 170 millon dollars.  rate and reply
0 stars

Big news

And the data further supports the data in patients that haven't undergone surgery. THE EXTENT OF THE PROBLEM The true incidence of postoperative atrial fibrillation (POAF) following cardiac surgery...read more
1 star

Note to investox (greedy Gus)

This TKO speculation is not within your purview to do so, other than to just fatten your own portfolio,  rate and reply
0 stars

Takeover speculation ?

The time is ripe for the takeover of Medicure. Thus the Aggrastat distribution rights would be completely at Cardiome. Medicure should therefore receive a takeover bid.  rate and reply
1 star

Aggrastat .... Medicure, Correvio and Cardiome !

Market value very low 3.2 million CAD dollars.(Shares outstanding 12,100,000) Significant revaluation for Medicure after Correvio takeover by Cardiome.Medicure Pharma, Inc. Medicure's core focus is on...read more
1 star

Correvio and AGGRASTAT ... Medicure and AGGRASTAT

http://www.stockhouse.com/news/press-releases/2013/11/18/cardiome-to-acquire-correvio-llc  rate and reply
1 star

CARDIOME PURCHASE OFFER for Medicure?

Medicure V.MPH Medicure's core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT. The Company has an experienced commercial team dedicated exclusively to the marketing...read more
0 stars

RE:Bought this yesterday and already up 17%

Is this "the Sir_Holler" from the ID Biomedical board a few years back?  rate and reply
0 stars

RE:RE:RE:Facts are best?

Oh, I'd be really happy if it just goes to $40!  rate and reply

Private Equity


Own a piece of our private equity marketplace: Limited to 50 members.

Click here to watch video 4

How to invest in private equity without writing a $1 million check.

Click here to watch video 3

Why the wealthy are 23x wealthier than the average investor.

Click here to watch video 2

Private Equity: Find out why it returned 16% p.a. for 10 years.


Click here to watch video 1